A Fort Worth Based Biotech Company, Nuvothera, has launched an improved version of the Prosoria psoriasis treatment system for this tough-to-treat skin condition. The new and enhanced two-step treatment easier than the original three-step system. It now includes a treatment gel and an exfoliating moisturizing cream. The relieving and effectiveness results are the same as users have come to expect from Prosoria’s 3-step combination. The process became more accessible as the improved version needs to be used only two times instead of three and will still provide the same results.
During the second quarter of 2021, a treatment for scalp conditions will debut. Approximately 9 million people in the U.S. have psoriasis and 125 million worldwide. The dry, flaky patches of skin are the recognition of the disease, and similar to rheumatoid arthritis, it is an inherited inflammatory condition and not contagious.
CEO of Nuvothera, Art Clapp, said, “We knew with the advanced pharmaceutical technology we have today that we could make a better and more effective ‘over-the-counter’ treatment that was safe to use every day. We are constantly seeking ways to improve our customers’ experience. With the proper approach – now easier to use — psoriasis symptoms can be well controlled.”